Nanjing Well Pharmaceutical Technology Co., Ltd

Nanjing Well Pharmaceutical Technology Co., Ltd. is a wholly-owned subsidiary of the Group, and it is a new R&D and manufacturing center for pharmaceutical excipients and APIs of the Well Group. The project is located in Nanjing Jiangbei New Material Science and Technology Park,

• >Excipients for Injection
• >Excipients for Oral and Topical Applications
• >Active Pharmaceutical Ingredients API

Nanjing Well Biomaterial Co., Ltd

Nanjing Well Biomaterial Co., Ltd. is a wholly-owned subsidiary of Nanjing Well Pharmaceutical Group Co., LTD. (Stock code: 603351). The company is specialized in the research, production and sales of agricultural surface activity, and has advanced production facilities and applied research facilities for surfactant in China.

• >Text of instruction
• >Recommended product text

Nanjing Well Biotechnology Co., Ltd

Nanjing Well Biotechnology Co., Ltd is the wholly-owned subsidiary of Nanjing Well pharmaceutical Group Co., Ltd (Stock abbreviation:” Well Pharmaceutical”, stock code: 603351). Well get progress from heritage for 50 years, dedicated to research

• >Biotechnology product range

扬州威尔生物科技有限公司

扬州威尔生物科技有限公司是南京威尔药业集团（股票代码603351）控股子公司，是一家集研发、生产、销售和服务的科技型动物营养与保健品公司。

• >威尔达系列

南京威尔材料科技研究院有限公司

南京威尔材料科技研究院有限公司是南京威尔药业集团股份有限公司（简称“威尔药业”，股票代码：603351）的全资子公司。历经二十余年的发展，研究院致力于高端药用辅料、原料药、医用高分子材料、润滑新材料、生物基材料、健康食品及动物保健添加剂等的开发及应用研究。

南京威尔健康科技有限公司

南京威尔健康科技有限公司是威尔药业集团股份有限公司（股票简称“威尔药业”，股票代码：603351）的控股子公司。公司充分整合集团内外的相关资源，利用化学法、物理法、色谱法、生物酶法等技术攻克油脂中Ω-3,6,7,9 脂肪酸类成分分离纯化。通过特殊生物酶实现结构脂肪的生物改性和脂肪酸碳链延长等关键技术。

• >威尔健康产品系列